Groundbreaking research is investigating adolescent cannabis use disorder biomarkers in the endocannabinoid and opioid systems. This study could identify predictive markers for relapse risk in young patients. The findings may transform how clinicians approach treatment planning for adolescent cannabis dependence.
[no_toc] Study Review • Psychiatry • Evidence Interpretation Cannabis Use Disorder Psychiatric Risk: What This 2026 Study Actually Shows A careful review of a large new study comparing cannabis use disorder with...